Cargando…
Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma
Immunotherapy based on anti-PD1 antibodies has improved the outcome of advanced melanoma. However, prediction of response to immunotherapy remains an unmet need in the field. Tumor PD-L1 expression, mutational burden, gene profiles and microbiome profiles have been proposed as potential markers but...
Autores principales: | Trilla-Fuertes, Lucía, Gámez-Pozo, Angelo, Prado-Vázquez, Guillermo, López-Vacas, Rocío, Zapater-Moros, Andrea, López-Camacho, Elena, Lumbreras-Herrera, María I., Soriano, Virtudes, Garicano, Fernando, Lecumberri, Mª José, Rodríguez de la Borbolla, María, Majem, Margarita, Pérez-Ruiz, Elisabeth, González-Cao, María, Oramas, Juana, Magdaleno, Alejandra, Fra, Joaquín, Martín-Carnicero, Alfonso, Corral, Mónica, Puértolas, Teresa, Ramos, Ricardo, Fresno Vara, Juan Ángel, Espinosa, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821399/ https://www.ncbi.nlm.nih.gov/pubmed/36614248 http://dx.doi.org/10.3390/ijms24010801 |
Ejemplares similares
-
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2023) -
Proteomics Characterization of Clear Cell Renal Cell Carcinoma
por: Miranda-Poma, Jesús, et al.
Publicado: (2023) -
Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2022) -
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020) -
Melanoma proteomics suggests functional differences related to mutational status
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2019)